"* Більше 10-ти років професійної медичної допомоги. * Кваліфіковані лікарі з понад 10-річним досвідом. * Консультативний прийом кандидатів наук. * УЗД діагностика на апаратах експертного класу. * Понад 400 видів лабораторних аналізів. * Широкий асортимент європейських вакцин. * Високоточна функціональна діагностика. * Багаторівнева система контролю якості."

During the past decade, Salutem Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Salutem Medical Center" are "Multiple Sclerosis, Primary Progressive" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Salutem Medical Center" in a lesser frequency.

Most popular intervention types in "Salutem Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fenebrutinib" (2 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials), "Placebo matched to fenebrutinib" (1 trials) and "Placebo matched to ocrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Salutem Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Salutem Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Salutem Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Salutem Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".